240. New Antimicrobial Drug Development: Saturday, 12:15 - 1:30 p.m.
Poster Session: New Antimicrobial Drug Development
Emma L. Harvey, BSc, MBBS, MRCP, FFPM (she/her/hers)
Global Head of Medical Affairs
F2G Ltd
Manchester, England, United Kingdom
Mark Bresnik, MD
Executive Director, Clinical R&D
F2G, Ltd.
Princeton, New Jersey, United States
Tara Symonds, PhD
Clinical Outcomes Solutions
Folkestone, England, United Kingdom
Elliott Blatt, MPH
Research Scientist I
Clinical Outcomes Solutions
Tucson, Arizona, United States
Sophie Hughes, MSc
Research Associate II
Clinical Outcomes Solutions
Kent, England, United Kingdom
Rob Purdie, n/a
Co-Founder
Mycology Advocacy, Research & Education (MYCARE)
Bakersfield, California, United States
Jennifer L. Clegg, MA
Associate Director I
Clinical Outcomes Solutions
Chicago, Illinois, United States